Here's why the Medibank share price is up 15% over the last month

Medibank Private Ltd (ASX: MPL) also boasts a higher dividend yield than rival NIB Holdings Ltd (ASX: NHF).

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) share price continues to enjoy the glow of the Coalition's shock federal election victory with it up 15% over just the last month and up 33% over the past year. That's some good growth for a company that has the amount it can put private healthcare premiums up by every year regulated by the federal government.

One reasons investors are probably bidding Medibank and NIB Holdings Ltd (ASX: NHF) shares higher is the belief that the Coalition government will encourage more people to take up private health insurance policies via increases to the Medicare levy or less generous spending on Medicare and its rebate system.

NIB shares are up around 15% since the election result and close to a 52-week high of $6.88.

Medibank offers investors some defensive revenues and dividends thanks to its reliable premiums paid by its huge amount of members.

At $3.33 the stock offers a trailing yield of 3.9% plus full franking credits based on 12.9 cents per share in dividends handed out over the past 12 months. On the same basis NIB's trailing yield is 3.1% fully franked.

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: How does Morgans rate these ASX shares?

Morgans has been looking at a couple of popular shares.

Read more »

A man pulls a shocked expression with mouth wide open as he holds up his laptop.
Broker Notes

Why this beaten down ASX 200 stock could rise 50%

This stock could be dirt cheap according to analysts at Bell Potter.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Share Market News

4 pros and cons of buying the Vanguard Australian Shares ETF (VAS) in 2026!

This popular ETF isn't a slam dunk...

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why 4DMedical, Regis Resources, Unico Silver, and WiseTech Global shares are pushing higher

These shares are having a good time on hump day. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Bellevue Gold, Harvey Norman, Karoon Energy, and Westpac shares are falling today

These shares are having a tough time on hump day. But why?

Read more »

woman testing substance in laboratory dish, csl share price
Share Market News

After a 73% surge this ASX healthcare share looks far from done

Brokers are upbeat, and some see possible gains of 90% in 2026.

Read more »

A man in his 30s with a clipped beard sits at his laptop on a desk with one finger to the side of his face and his chin resting on his thumb as he looks concerned while staring at his computer screen.
Share Market News

Magellan Financial Group dips as AUM slips in December quarter

Magellan Financial Group's AUM declined to $39.9 billion at December 2025, with net outflows for the quarter.

Read more »

Man presses green buy button and red sell button on a graph.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »